Information  X 
Enter a valid email address

Volvere PLC (VLE)

  Print      Mail a friend       Annual reports

Monday 29 June, 2020

Volvere PLC

Result of AGM

RNS Number : 4159R
Volvere PLC
29 June 2020
 

 

 

 

Volvere plc

("Volvere" or the "Company")

Result of AGM

Volvere announces that all the resolutions proposed at the Annual General Meeting of the Company, held earlier today, were duly passed.

The votes cast on a poll for each resolution were as follows:

Resolution

For

Against

Withheld

Resolution 1 - To re-appoint Jonathan Lander as a Director

285,908

0

0

Resolution 2 - To re-appoint David Buchler as a Director

285,371

0

537

Resolution 3 - To receive and consider the Company's accounts for the financial year ended 31 December 2019

285,908

0

0

Resolution 4 - To re-appoint James Cowper LLP as auditor

285,908

0

0

Resolution 5 - To authorise the Company's audit committee to determine the remuneration of the auditor

285,908

0

0

Resolution 6 - THAT the Directors be authorised for the purposes of Section 551 of the Companies Act 2006 to allot equity securities

285,295

 

613

0

Resolution 7 - THAT the investing strategy of the Company as set out in the Circular be and is hereby approved

285,908

0

0

Resolution 8 - THAT the Directors be empowered to allot equity securities (as defined in section 560 of the Act) wholly for cash

285,295

613

0

Resolution 9 - THAT the Company be authorised to make one or more market purchases of Ordinary Shares

285,366

537

0

 

For further information contact:

 

Volvere plc


Jonathan Lander, CEO

Tel: + 44 (0) 20 7634 9707

 

 

www.volvere.co.uk

 

Cairn Financial Advisers LLP

Sandy Jamieson/James Lewis

 

Tel: + 44 (0) 20 7213 0880

 

Hobart Capital Markets LLP

Lee Richardson 

 

Tel: + 44 (0) 20 7070 5691

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RAGFLFVVRLIAFII

a d v e r t i s e m e n t